Artículos

Stroke and Emerging Blood Biomarkers: A Clinical Prospective

Stroke and Emerging Blood Biomarkers: A Clinical Prospective Abstract Stroke constitutes the primary source of adult functional disability, exhibiting a paramount socioeconomic burden. Thus, it is of great importance that the prediction of stroke outcome be both prompt and accurate. Although modern neuroimaging and neurophysiological techniques are accessible, easily available blood biomarkers reflecting underlying stroke-related […]

Read More

Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023

Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023 As the global prevalence of peritoneal dialysis (PD) continues to grow, practitioners must be equipped with prescribing strategies that focus on the needs and preferences of patients. PD is an effective form of kidney replacement therapy that offers numerous benefits to patients, including more […]

Read More

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Resumen Apuntar La “Guía de la AHA/ACC/HFSA de 2022 para el tratamiento de la insuficiencia cardíaca” reemplaza la “Guía de la ACCF/AHA de 2013 para el tratamiento de la insuficiencia […]

Read More

Manejo de la hiperglucemia en pacientes adultos hospitalizados en entornos de cuidados no críticos: una guía de práctica clínica de la Endocrine Society

Manejo de la hiperglucemia en pacientes adultos hospitalizados en entornos de cuidados no críticos: una guía de práctica clínica de la Endocrine Society Las recomendaciones se basan en la consideración de resultados importantes, practicidad, viabilidad y valores y preferencias del paciente. Estas recomendaciones se pueden utilizar para informar la mejora del sistema y la práctica clínica […]

Read More

The management of acute and chronic hyponatraemia

The management of acute and chronic hyponatraemia Abstract Hyponatraemia is the most common electrolyte abnormality encountered in clinical practice; despite this, the work-up and management of hyponatraemia remain suboptimal and varies among different specialist groups. The majority of data comparing hyponatraemia treatments have been observational, up until recently. The past two years have seen the […]

Read More

Current applications and limitations of European guidelines on blood pressure measurement: implications for clinical practice

Current applications and limitations of European guidelines on blood pressure measurement: implications for clinical practice  Abstract Hypertension is the most common cardiovascular (CV) risk factor, strongly and independently associated with an increased risk of major CV outcomes, including myocardial infarction, stroke, congestive heart failure, renal disease and death due to CV causes. Effective control of […]

Read More

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update […]

Read More

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis Introduction Patients with cirrhosis frequently acquire substantial alterations in their haemostatic system that are apparent during screening with basic tests of haemostasis (mainly international normalised ratio [INR], activated partial thromboplastin time [APTT] and platelet count). Historically, these changes were […]

Read More

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future Abstract Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality among people living with diabetes, and is one of the most important causes of end stage renal disease worldwide. In order to reduce […]

Read More

Management of hypertensive emergencies: a practical approach

Management of hypertensive emergencies: a practical approach Abstract Background: Acute increases of high blood pressure values, usually described as ‘hypertensive crises’, ‘hypertensive urgencies’ or ‘hypertensive emergencies’, are common causes of patients’ presentation to emergency departments. Owing to the lack of ad hoc randomized clinical trials, current recommendations/suggestions for treatment of these patients are not evidenced-based and, […]

Read More